These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 37278710)
21. Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center. Tinsley A; Naymagon S; Enomoto LM; Hollenbeak CS; Sands BE; Ullman TA J Crohns Colitis; 2013 Dec; 7(12):e635-40. PubMed ID: 23706933 [TBL] [Abstract][Full Text] [Related]
22. Predictors and safety of venous thromboembolism prophylaxis among hospitalized inflammatory bowel disease patients. Ra G; Thanabalan R; Ratneswaran S; Nguyen GC J Crohns Colitis; 2013 Nov; 7(10):e479-85. PubMed ID: 23537817 [TBL] [Abstract][Full Text] [Related]
23. Thrombosis in inflammatory bowel disease: are we tailoring prophylaxis to those most at risk? Bryant RV; Jairath V; Curry N; Travis SP J Crohns Colitis; 2014 Feb; 8(2):166-71. PubMed ID: 24095288 [TBL] [Abstract][Full Text] [Related]
24. Venous thromboembolism in inflammatory bowel disease. Cheng K; Faye AS World J Gastroenterol; 2020 Mar; 26(12):1231-1241. PubMed ID: 32256013 [TBL] [Abstract][Full Text] [Related]
25. Survey of perceptions and practices among Canadian gastroenterologists regarding the prevention of venous thromboembolism for hospitalized inflammatory bowel disease patients. Razik R; Bernstein CN; Sam J; Thanabalan R; Nguyen GC Can J Gastroenterol; 2012 Nov; 26(11):795-8. PubMed ID: 23166902 [TBL] [Abstract][Full Text] [Related]
26. Venous Thromboembolism Risk in Asian Patients with Inflammatory Bowel Disease: A Population-Based Nationwide Inception Cohort Study. Kim SY; Cho YS; Kim HS; Lee JK; Kim HM; Park HJ; Kim H; Kim J; Kang DR Gut Liver; 2022 Jul; 16(4):555-566. PubMed ID: 34789583 [TBL] [Abstract][Full Text] [Related]
27. [Prevention and treatment of thromboembolism in patients with inflammatory bowel disease]. Park JJ Korean J Gastroenterol; 2015 Mar; 65(3):151-8. PubMed ID: 25797378 [TBL] [Abstract][Full Text] [Related]
28. Physicians' perceptions of risks and practices in venous thromboembolism prophylaxis in inflammatory bowel disease. Sam JJ; Bernstein CN; Razik R; Thanabalan R; Nguyen GC Dig Dis Sci; 2013 Jan; 58(1):46-52. PubMed ID: 23053902 [TBL] [Abstract][Full Text] [Related]
29. Unawareness of thromboprophylaxis is associated with low venous thromboembolism occurrence in hospitalized patients with acute inflammatory bowel disease flare. Sbeit W; Kadah A; Shafrir A; Kalisky I; Mahamid M; Hazou W; Katz L; Mari A; Khoury T Minerva Med; 2020 Dec; 111(6):560-565. PubMed ID: 32729705 [TBL] [Abstract][Full Text] [Related]
30. Disease activity and venous thromboembolism in inflammatory bowel disease. Ghosh T; Ford AC; Everett S Lancet; 2010 May; 375(9727):1690; author reply 1690-1. PubMed ID: 20472161 [No Abstract] [Full Text] [Related]
32. Venous thromboembolism in inflammatory bowel disease: an epidemiological review. Murthy SK; Nguyen GC Am J Gastroenterol; 2011 Apr; 106(4):713-8. PubMed ID: 21407182 [TBL] [Abstract][Full Text] [Related]
33. Disease activity and venous thromboembolism in inflammatory bowel disease. Koutroubakis IE; Pena AS Lancet; 2010 May; 375(9727):1689; author reply 1690-1. PubMed ID: 20472159 [No Abstract] [Full Text] [Related]
34. Venous thromboembolism in patients with inflammatory bowel disease: focus on prevention and treatment. Papa A; Gerardi V; Marzo M; Felice C; Rapaccini GL; Gasbarrini A World J Gastroenterol; 2014 Mar; 20(12):3173-9. PubMed ID: 24695669 [TBL] [Abstract][Full Text] [Related]
35. Risk of venous thromboembolism in patients with chronic liver disease and the utility of venous thromboembolism prophylaxis. Pincus KJ; Tata AL; Watson K Ann Pharmacother; 2012 Jun; 46(6):873-8. PubMed ID: 22570429 [TBL] [Abstract][Full Text] [Related]
36. [Inflammatory bowel disease and venous thromboembolisms]. Delhougne N; Colard A; Louis E Rev Med Liege; 2018 Sep; 73(9):462-467. PubMed ID: 30188032 [TBL] [Abstract][Full Text] [Related]
37. Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism : a cohort study. Flanders SA; Greene MT; Grant P; Kaatz S; Paje D; Lee B; Barron J; Chopra V; Share D; Bernstein SJ JAMA Intern Med; 2014 Oct; 174(10):1577-84. PubMed ID: 25133488 [TBL] [Abstract][Full Text] [Related]
38. Venous and arterial thromboembolism in patients with inflammatory bowel diseases. Stadnicki A; Stadnicka I World J Gastroenterol; 2021 Oct; 27(40):6757-6774. PubMed ID: 34790006 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of pharmacologic prophylaxis for venous thromboembolism in patients with chronic liver disease. Barclay SM; Jeffres MN; Nguyen K; Nguyen T Pharmacotherapy; 2013 Apr; 33(4):375-82. PubMed ID: 23553808 [TBL] [Abstract][Full Text] [Related]